Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity.
Anft M, Paniskaki K, Giglio T, Wellenkötter J, Blazquez-Navarro A, Meister TL, Roch T, Giesecke-Thiel C, Westhoff TH, Stervbo U, Pfaender S, Cinkilic O, Babel N. Anft M, et al. Among authors: blazquez navarro a. Kidney Int. 2023 Jan;103(1):223-225. doi: 10.1016/j.kint.2022.10.012. Epub 2022 Nov 1. Kidney Int. 2023. PMID: 36332726 Free PMC article. No abstract available.
SARS-CoV-2-reactive cellular and humoral immunity in hemodialysis population.
Anft M, Blazquez-Navarro A, Paniskaki K, Skrzypczyk S, Appel H, Pfab T, Uhle A, Frahnert M, Barenbrock M, Büssemaker E, Hörstrup J, Doevelaar A, Seibert FS, Hölzer B, Stervbo U, Dolff S, Witzke O, Babel N, Westhoff TH. Anft M, et al. Kidney Int. 2021 Jun;99(6):1489-1490. doi: 10.1016/j.kint.2021.03.032. Epub 2021 Apr 20. Kidney Int. 2021. PMID: 33887319 Free PMC article. No abstract available.
Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients.
Blazquez-Navarro A, Safi L, Meister TL, Thieme CJ, Kaliszczyk S, Paniskaki K, Stockhausen M, Hörstrup J, Cinkilic O, Flitsch-Kiefner L, Marheinecke C, Steinmann E, Seibert FS, Stervbo U, Westhoff TH, Pfaender S, Roch T, Babel N. Blazquez-Navarro A, et al. Kidney Int. 2021 Sep;100(3):698-700. doi: 10.1016/j.kint.2021.07.006. Epub 2021 Jul 14. Kidney Int. 2021. PMID: 34273381 Free PMC article. No abstract available.
A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse.
Westhoff TH, Seibert FS, Anft M, Blazquez-Navarro A, Skrzypczyk S, Zgoura P, Meister TL, Pfaender S, Stumpf J, Hugo C, Viebahn R, Roch T, Stervbo U, Babel N. Westhoff TH, et al. Kidney Int. 2021 Nov;100(5):1135-1136. doi: 10.1016/j.kint.2021.09.001. Epub 2021 Sep 9. Kidney Int. 2021. PMID: 34509489 Free PMC article. No abstract available.
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease.
Stervbo U, Blazquez-Navarro A, Blanco EV, Safi L, Meister TL, Paniskaki K, Stockhausen M, Marheinecke C, Zimmer G, Wellenkötter J, Giglio T, Arora P, Pöhlmann S, Hoffmann M, Seibert FS, Pfaender S, Roch T, Westhoff TH, Cinkilic O, Babel N. Stervbo U, et al. Kidney Int. 2021 Dec;100(6):1335-1337. doi: 10.1016/j.kint.2021.09.015. Epub 2021 Oct 4. Kidney Int. 2021. PMID: 34619233 Free PMC article. No abstract available.
A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant Recipients.
Roch T, Rohn B, Blazquez-Navarro A, Meister TL, Blanco EV, Paniskaki K, Wellenkötter J, Zgoura P, Giglio T, Pfaender S, Stervbo U, Viebahn R, Cinkilic O, Westhoff TH, Babel N. Roch T, et al. Kidney Int Rep. 2022 Apr;7(4):932-934. doi: 10.1016/j.ekir.2022.01.1068. Epub 2022 Feb 1. Kidney Int Rep. 2022. PMID: 35128216 Free PMC article. No abstract available.
Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses.
Cinkilic O, Anft M, Blazquez-Navarro A, Meister TL, Roch T, Stervbo U, Pfaender S, Westhoff TH, Babel N. Cinkilic O, et al. Kidney Int. 2022 Jun;101(6):1287-1289. doi: 10.1016/j.kint.2022.03.005. Epub 2022 Mar 14. Kidney Int. 2022. PMID: 35301007 Free PMC article. No abstract available.
Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses.
Anft M, Blazquez-Navarro A, Frahnert M, Fricke L, Meister TL, Roch T, Stervbo U, Pfaender S, Westhoff TH, Babel N. Anft M, et al. Among authors: blazquez navarro a. Kidney Int. 2022 Jul;102(1):207-208. doi: 10.1016/j.kint.2022.05.004. Epub 2022 May 14. Kidney Int. 2022. PMID: 35580654 Free PMC article. No abstract available.
Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients.
Thieme CJ, Anft M, Paniskaki K, Blazquez-Navarro A, Doevelaar A, Seibert FS, Hoelzer B, Konik MJ, Berger MM, Brenner T, Tempfer C, Watzl C, Meister TL, Pfaender S, Steinmann E, Dolff S, Dittmer U, Westhoff TH, Witzke O, Stervbo U, Roch T, Babel N. Thieme CJ, et al. Cell Rep Med. 2020 Sep 22;1(6):100092. doi: 10.1016/j.xcrm.2020.100092. Epub 2020 Aug 29. Cell Rep Med. 2020. PMID: 32904468 Free PMC article.
36 results